OA 05.06 Phase 2 Study of Lorlatinib in Patients with Advanced ALK+/ROS1+ Non-Small-Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

OA 05.06 Phase 2 Study of Lorlatinib in Patients with Advanced ALK+/ROS1+ Non-Small-Cell Lung Cancer

DOI Full Paper Access

34

Citations

0

References

2017

Year

Benjamin Solomon, Alice T. Shaw, Sai‐Hong Ignatius Ou, Benjamin Besse, Enriqueta Felip, Todd M. Bauer, Ross A. Soo, Alessandra Bearz, Chiou‐Feng Lin, Jill S. Clancy,

Journal of Thoracic Oncology

MedicinePathologyBronchial NeoplasmMolecular OncologyCancer TreatmentPhase 2OncologyRadiation OncologyLung CancerCancer ResearchCancer Growth

No additional data available for this publication yet. Check back later!